FDA — authorised 27 June 1960
- Marketing authorisation holder: WYETH PHARMS INC
- Status: approved
🇺🇸 Phospholine Iodide in United States
FDA authorised Phospholine Iodide on 27 June 1960
Marketing authorisations
FDA — authorised 27 June 1960
- Application: NDA011963
- Marketing authorisation holder: FERA PHARMS LLC
- Local brand name: PHOSPHOLINE IODIDE
- Indication: FOR SOLUTION — OPHTHALMIC
- Status: approved
Phospholine Iodide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Phospholine Iodide approved in United States?
Yes. FDA authorised it on 27 June 1960; FDA authorised it on 27 June 1960.
Who is the marketing authorisation holder for Phospholine Iodide in United States?
WYETH PHARMS INC holds the US marketing authorisation.